您的位置: 首页 >会议日程
Steven H. Wong
单位: Wake Forest University School of Medicine, Winston-Salem, NC, USA 科室: -
简历:

Steven H. Wong, Ph.D., DABCC (TC), FACB, is Professor of Pathology with tenure, Director of Clinical Chemistry and Toxicology/Core Laboratory, Department of Pathology, Wake Forest School of Medicine. He is Co-Director of Clinical and Translational Mass Spectrometry Center. Dr. Wong’s current scientific and clinical interests encompass clinical and translational applications of omics biomarkers for enabling personalized medicine and personalized justice: pharmacogenomics, proteomics, metabolomics, and mass spectrometry for clinical chemistry., TDM with emphasis on immunosuppressant and pain management therapy with adjunct pharmacogenomics and metabolomics., and oral fluid proteome and metabolome for clinical and forensic toxicology/workplace testing. In addition to over 125 publications and 157 abstracts, he edited/co-edited four books including Pharmacogenomics and Proteomics: Enabling the Practice of Personalized Medicine.

 

Prior to joining Wake Forest, Dr. Wong was a Professor of Pathology, Director/Co-Director, Clinical Chemistry/Toxicology, TDM, Pharmacogenomics and Proteomics, Department of Pathology, Medical College of Wisconsin.  He also served as the Toxicology Scientific Director at the Milwaukee County Medical Examiner’s Office. He was an Associate Professor, and Director, Drug Analysis Division of the Department of Laboratory Medicine, University of Connecticut School of Medicine., and Associate Professor of Pathology and Associate Director of Clinical Chemistry, Johns Hopkins University School of Medicine.

 

An active American Association for Clinical Chemistry (AACC) member since 1980, Dr. Wong was the 2014 AACC President. He is a member of AACC Academy, and of four divisions: TDM-CT (Founding Chair), Proteomics (Past Chair), Molecular Pathology (Past Chair), and Mass Spectrometry and Separation Science (Founding member). Outside AACC, Dr. Wong is a member of the Drug Testing Advisory Board of Substance Abuse and Mental Health Services Administration/DHHS, and a former member of the Antibody Committee of the National Cancer Institute/NIH, and the newly established Foundation of NIH - Cancer Steering Committee/Biomarkers Consortium Working Group on Proteomic Assay Harmonization. In 2016, as part of the NCI Cancer Moonshot, he was appointed as a member of the Applied Proteogenomics Organizational Learning and Outcomes Network (APOLLO)/Technology Working Group. In 2017, he was appointed to the Pain Committee of Wake Forest School of Medicine. He was a reviewer for NIH Glue grants. He served on the American Board of Clinical Chemistry. He received the Young Investigator’s Award from the Association of Clinical Scientists., Seligson/Golden and the Samuel Natelson Awards of AACC., and the FDA–CDRH Certificate of Appreciation from the FDA/Stakeholder TDM Review Development Team. He was the founding President of the International Association for TDM and Clinical Toxicology. He is an editorial board member for Clinical Mass Spectrometry, Pharmacogenomics, Therapeutic Drug Monitoring, Annuals of Clinical & Laboratory Science, and a past board member for Clinical Chemistry and Laboratory Medicine and Journal of Analytical Toxicology.

 


... 更多
 
分享至:

学术任务如下:

日期 时间 会场 Session/主题 角色 姓名 单位
2019-08-30 13:05-13:40 A106

中美质谱高峰论坛1(主席:郭玮,潘柏申)

Next Generation Mass Spectrometry for Transplant, Umbilical cord, Forensic and Renal Metabolomics
讲者

Steven H. Wong

Wake Forest University School of Medicine, Winston-Salem, NC, USA